Venlafaxine vs. fluoxetine in postmenopausal women with major depressive disorder: an 8-week, randomized, single-blind, active-controlled study

https://t.co/CUvqJsQo1h

RCT: After 8-weeks, venlafaxine was better than fluoxetine in the reduction of HAMD-24 scores in postmenopausal women with MDD (LS MD= − 2.22; −7.08 to − 0.41). There was no difference in the incidence of adverse events between the two medications https://

Venlafaxine vs. fluoxetine in postmenopausal women with major depressive disorder: an 8-week, randomized, single-blind, active-controlled study https://t.co/Ri9xgPpByb